Stemonix CEO Ping Yeh meets Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. The company creates stem-cell derived human tissue for custom drug discovery and personalized medicine.
StemoniX explains how they can create human micro-organs and the life-changing impact it will have
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE